Abstract
Most texts and review articles on venoms have been primarily concerned with chemical properties or mechanisms of action (Bücherl et al., 1968; Jiménez-Porras, 1968; Devi, 1968; Sarkar and Devi, 1968; Russell, 1967; Russell and Saunders, 1967; Condrea and de Vries, 1965; Meldrum, 1965; Braganca and Aravindakshan, 1962; Buckley and Porges, 1956; Zeller, 1951). Indeed, understanding of the pharmacological actions of venoms was greatly aided by the study of their effects on various organ systems such as nerve, muscle, and blood. It was, however, not so readily apparent that this complex, specialized saliva of snakes could be used as a tool for analysis of physiological processes. For example, by 1963 about 6000 papers on snake venoms and venomous snakes had been published (Russell and Scharf-fenberg, 1964), with relatively few of these having as their direct concern a better understanding of the physiological processes affected by venoms. A notable exception was the process of blood coagulation, which has been clarified by studying the action of snake venoms or venom components (Jimenez-Porras, 1968; Condrea and DeVries, 1965; Boquet, 1964). Snake venoms have also been useful as tools in general biochemical research, where the primary interest has been in extracting and studying enzymes obtained from venoms (Zeller, 1966).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, R. D. and E. P. Richardson (1961), The demyelinating diseases of the human nervous system, in “Chemical Pathology of the Nervous System” (J. Folch-Pi, ed.) Pergamon Press, New York, pp. 162–194.
Angeletti, P. U., P. Calissano, J. S. Chen, and R. Levi-Montalcini (1967), Biochim. Biophys. Acta, 147:180.
Beiler, J. M., R. Brendel, and G. J. Martin (1956), J. Pharmacol Exp. Therap., 118:415.
Birkmayer, W. and E. Neumayer (1957), Deut. Z. Nervenheilk, 177:117.
Boquet, P. (1964), Toxicon, 2:5.
Braganca, B. M. and I. Aravindakshan (1962), Neurochemical effects of snake venoms, in “Neurochemistry” (A. C. Elliott, I. H. Page, and J. H. Quastel, eds.), Charles C. Thomas, Springfield, Ill., pp. 840–850.
Braganca, B. M. and J. H. Quastel (1952), Nature, 169:695.
Braganca, B. M. and J. H. Quastel (1953), Biochem. J., 53:88.
Brzin, ML, W.-D. Dettbarn, and P. Rosenberg (1965a), Biochem. Pharmacol., 14:919.
Brzin, M., W.-D. Dettbarn, P. Rosenberg, and D. Nachmansohn (1965b), J. Cell Biol., 26:353.
Brzin, M., V. M. Tennyson, and P. E. Duffy (1966), J. Cell Biol., 31:215.
Bücherl, W., E. E. Buckley, and V. Deulofeu (eds.) (1968), “Venomous Animals and Their Venoms,” vol. 1, Academic Press, New York.
Buckley, E. E. and N. Porges (eds.), 1956, “Venoms,” American Association for the Advancement of Science, Washington, D.C.
Bullock, T. H., D. Nachmansohn, and M. A. Rothenberg (1946), J. Neurophysiol, 9:9.
Chang, C. C. (1960), J. Formosan Med. Ass., 59:315.
Chatterjee, A. K. (1949), Indian J. Med. Res., 37:241.
Cohen, S. (1958), A nerve growth promoting protein, in “Chemical Basis of Development,” Johns Hopkins Press, Baltimore, pp. 665–667.
Cohen, S. (1959), J. Biol. Chem., 234:1129.
Cohen, S. and R. Levi-Montalcini (1956), Proc. Nat. Acad. Sci., 42:571.
Condrea, E. and A. de Vries, Toxicon, 2:261.
Condrea, E. and P. Rosenberg (1968), Biochim. Acta, 150:271.
Condrea, E., A. de Vries, and J. Mager (1962), Biochim. Biophys. Acta, 58:389.
Condrea, E., A. de Vries, and J. Mager (1964), Biochim. Biophys. Acta, 84:60.
Condrea, E., Y. Avi-Dor, and J. Mager (1965), Biochim. Biophys. Acta, 110:337.
Condrea, E., P. Rosenberg, and W.-D. Dettbarn (1967), Biochim. Biophys. Acta, 135:669.
Delezenne, C. and S. Ledebt (1911), C. R. Acad. Sci. (Paris), 152:790.
Delezenne, C. and S. Ledebt (1912), C. R. Acad. Sci. (Paris), 155:1101.
Dettbarn, W.-D. (1963), Life Sciences, 12:910.
Dettbarn, W.-D. and F. A. Davis (1963), Biochim. Biophys. Acta, 66:397.
Dettbarn, W.-D. and F. C. G. Hoskin (1962), Biochim. Biophys. Acta, 62:566.
Dettbarn, W.-D. and P. Rosenberg (1962), Biochem. Pharmacol., 11:1025.
Dettbarn, W.-D. and P. Rosenberg (1966), J. Gen. Physiol., 50:447.
Dettbarn, W.-D., P. Rosenberg, and D. Nachmansohn (1964), Life Sciences, 3:55.
Devi, A. (1968), The protein and nonprotein constituents of snake venoms, in “Venomous Animals and Their Venoms” (W. Bücherl, E. E. Buckley, and V. Deulofeu, eds.), Academic Press, New York, pp. 119–165.
Eccles, J. C. (1964), “The Physiology of Synapses,” Academic Press, New York.
Edwards, S. W. and E. G. Ball (1954), J. Biol. Chem., 209:619.
Elliott, W. B., J. M. Augustyn, and C. Gans (1966), Mem. Inst. Butantan Simp. Intern., 33:411.
Feinstein, M. B. (1964), J. Gen. Physiol., 48:357.
Fleischer, B., A. Casu, and S. Fleischer (1966), Biochem. Biophys. Res. Comm., 24:189.
Gautrelet, J. and E. Corteggiani (1938), C. R. Acad. Sci., 207:465.
Gautrelet, J. and E. Corteggiani (1939), C. R. Soc. Biol., 131:951.
Goldman, D. E. (1964), Biophys. J., 4:167.
Green, D. E. and S. Fleischer (1963), Biochim. Biophys. Acta, 70:554.
Habermann, E. (1960), Arch. Exp. Pathol. Pharmak., 238:502.
Habermann, E. and B. Krusche (1962), Biochem. Pharmacol., 11:400.
Hadidian, Z. (1956), Proteolytic activity and physiologic and pharmacologic actions of Agkistrodon piscivorus venom, in “Venoms” (E. E. Buckley and N. Porges, eds.) American Association for the Advancement of Science, Washington, D.C., pp. 205–215.
Heilbronn, E. (1969), J. Neurochem., 16:627.
Hodgkin, A. L. (1964), “The Conduction of the Nerve Impulse,” C. C. Thomas, Springfield, Ill.
Hokin, L. E. and M. R. Hokin (1963), The role of phosphatides in active transport with particular reference to sodium transport, in “Proc. First Int. Pharmacol. Meeting,” vol. 4, “Drugs and Membranes” (C. A. M. Hogben, ed.) The Macmillan Co., New York, pp. 23–40.
Hoskin, F. C. G. and P. Rosenberg (1964), J. Gen. Physiol., 47:1117.
Hoskin, F. C. G. and P. Rosenberg (1965), J. Gen. Physiol., 49:47.
Hoskin, F. C. G. and P. Rosenberg (1967), Science, 156:966.
Hoskin, F. C. G., P. Rosenberg, and M. Brzin (1966), Proc. Nat. Acad. Sci., 55:1231.
Hoskin, F. C. G., L. T. Kremzner, and P. Rosenberg (1969), Biochem. Pharmacol., 18:1727.
Hudson, A. J., J. H. Quastel, and P. G. Scholefield (1960), J. Neurochem., 5:177.
Hughes, A. (1935), Biochem. J., 29:437.
Hunter, W. K. (1909), Proc. R. Soc. Med., 3:105.
Ibraham, S. A., H. Saunders, and R. H. S. Thompson (1964), Biochem. J., 93:588.
Jiménez-Porras, J. M. (1968), Annual Review of Pharmacology, 8:299.
Katz, B. (1966), “Nerve, Muscle and Synapse,” McGraw-Hill Book Co., New York.
Kellaway, C. H. and H. F. Holden (1932), Aust. J. Exp. Biol. Med. Sci., 10:167.
Kirshmann, Ch., E. Condrea, N. Moav, S. Aloof, and A. de Vries (1964), Arch. Int. Pharmacodyn., 150:372.
Klibansky, C., J. Shiloah, and A. de Vries (1964), Biochem. Pharmacol., 13:1107.
Lamb, G. and W. K. Hunter (1904), Lancet, 1:20.
Lee, C. Y. and C. C. Chang (1966), Mem. Inst. Butantan Simp. Int., 33:555.
Lenard, J. and S. J. Singer (1966), Proc. Nat. Acad. Sci., 56:1828.
Lenard, J. and S. J. Singer (1968), Science, 159:738.
Levi-Montalcini, R. (1958), Chemical stimulation of nerve growth, in “Chemical Basis of Development” (W. D. McElroy and B. Glass, eds.), Johns Hopkins Press, Baltimore, pp. 646–664.
Levi-Montalcini, R. and P. U. Angeletti (1961), Biological properties of a nerve growth promoting protein and its antiserum, in “Regional Neurochemistry” (S. S. Kety and J. Elkes, eds.), Pergamon Press, New York, pp. 362–376.
Levi-Montalcini, R. and P. U. Angeletti (1968a), Physiol Rev., 48:534.
Levi-Montalcini, R. and P. U. Angeletti (1968b), Biological aspects of the nerve growth factor, in “Ciba Found. Symp. Growth of the Nervous System” (G. E. W. Wolstenholme and M. O’Connor, eds.), Churchill, London, pp. 126–147.
Levi-Montalcini, R. and B. Booker (1960a), Proc. Nat. Acad. Sci., 42:373.
Levi-Montalcini, R. and B. Booker (1960b), Proc. Nat. Acad. Sci., 42:384.
Levi-Montalcini, R. and S. Cohen (1956), Proc. Nat. Sci., 42:695.
Long, C. and M. F. Maguire (1954), Biochem. J., 57:223.
Macfarlane, M. G. (1950), Biochem. J., 47:267.
Macfarlane, M. G. and B. C. J. G. Knight (1941), Biochem. J., 35:884.
Magee, W. L. and R. H. S. Thompson (1960), Biochem. J., 77:526.
Martin, R. and P. Rosenberg (1968), J. Cell Biol., 36:341.
Meldrum, B. S. (1965), Pharmacol Rev., 17:393.
Minton, S. A. (1956), Some properties of North American pit viper venoms and their correlation with phylogeny, in “Venoms” (E. E. Buckley and N. Porges, eds.), American Association for the Advancement of Science, Washington, D.C., pp. 145–151.
Morazain, R. and P. Rosenberg (1970), Lipid changes in triorthocreasyl phosphate- induced neuropathy, Toxicol. Applied Pharmacol., 16, 461.
Morrison, L. R. and P. C. Zamecnik (1950), Arch. Neurol. Psychiat., 63:367.
Nachmansohn, D. (1959), “Chemical and Molecular Basis of Nerve Activity,” Academic Press, New York.
Nachmansohn, D. (1969), J. Gen. Physiol., 54:187s.
Narahashi, T. and J. M. Tobias (1964), Amer. J. Physiol., 207:1441.
Nelson, P. G. (1958), J. Cell. Comp. Physiol., 52:127.
Nygaard, A. P. and J. B. Sumner (1953), J. Biol. Chem., 200:723.
Nygaard, A. P., M. V. Dianzani, and G. F. Bahr (1954), Exp. Cell. Res., 6:453.
Okonogi, T., S. Hoshi, M. Honma, M. Mitsuhashi, S. Maeno, and Y. Sawai (1960), Jap. J. Microbiol, 4:297.
Petrushka, E., J. H. Quastel, and P. G. Scholefield (1959), Canad. J. Biochem. Physiol., 37:975.
Robertson, J. D. (1963), Unit membranes: a review with recent new studies of experimental alterations and a new subunit structure in synaptic membranes, in “Cellular Membranes in Development” (M. Locke, ed.) Academic Press, New York, p.1.
Rosenberg, P. (1960), Biochem. Pharmacol., 3:212.
Rosenberg, P. (1965), Toxicon, 3:125.
Rosenberg, P. (1966), Mem. Inst. Butantan Simp. Int., 33:477.
Rosenberg, P. (1970), Toxicon, in press.
Rosenberg, P. and E. Bartels (1967), J. Pharmacol Exp. Therap., 155:532.
Rosenberg, P. and E. Condrea (1968), Biochem. Pharmacol., 17:2033.
Rosenberg, P. and W.-D. Dettbarn (1963), Biochim. Biophys. Acta, 69:103.
Rosenberg, P. and W.-D. Dettbarn (1964), Biochem. Pharmacol., 13:1157.
Rosenberg, P. and W.-D. Dettbarn (1967), Use of venoms in testing for essentiality of Cholinesterase in conduction, in “Animal Toxins” (F. E. Russell and P. R. Saunders, eds.), Pergamon Press, New York, pp. 379–388.
Rosenberg, P. and S. Ehrenpreis (1961), Biochem. Pharmacol., 8:192.
Rosenberg, P. and H. Higman (1960), Biochim. Biophys. Acta, 45:348.
Rosenberg, P. and F. C. G. Hoskin (1963), J. Gen. Physiol., 46:1065.
Rosenberg, P. and F. C. G. Hoskin (1965), Biochem. Pharmacol., 14:1765.
Rosenberg, P. and H. G. Mautner (1967), Science, 155:1569.
Rosenberg, P. and K. Y. Ng (1963), Biochim. Biophys. Acta, 75:116.
Rosenberg, P. and T. R. Podleski (1962), J. Pharmacol Exp. Therap., 137:249.
Rosenberg, P. and T. R. Podleski (1963), Biochim. Biophys. Acta, 75:104.
Rosenberg, P., H. Higman, and D. Nachmansohn (1960), Biochim. Biophys. Acta, 44:151.
Rosenberg, P., H. G. Mautner, and D. Nachmansohn (1966), Proc. Nat. Acad. Sci., 55:835.
Rossiter, R. J. (1961), The chemistry of wallerian degeneration, in “Chemical Pathology of the Nervous System” (J. Folch-Pi, ed.), Pergamon Press, New York, pp. 207–230.
Rothenberg, M. A., D. B. Sprinson, and D. Nachmansohn (1948), J. Neurophysiol. 11:111.
Roy, A. C. (1945), Nature, 155:696.
Russell, F. E. (1967), Clin. Pharmacol. Therap., 8:849.
Russell, R. E. and T. E. Long (1961), Effects of venoms on neuromuscular transmission, in “Second International Symp. on Myasthenia gravis,” vol. III (H. R. Viets, ed.), Charles C. Thomas, Springfield, Ill., pp. 101–116.
Russell, F. E. and P. R. Saunders (eds.) (1967), “Animal Toxins,” Pergamon Press, New York.
Russell, F. E. and R. S. Scharffenberg (1964), “Bibliography of Snake Venoms and Venomous Snakes,” Bibliographic Associates, Inc., West Covina, Calif.
Sabatini, M. T., A. P. delraldi, and E. deRobertis (1965), J. Exp. Neurol., 12:370.
Sarkar, N. K. and A. Devi (1968), Enzymes in snake venoms, in “Venomous Animals and Their Venoms” (Bücherl, W., Buckley, E. E., and Deulofeu, V., eds.), vol. 1, Academic Press, New York, pp. 167–216.
Sjöstrand, F. X. (1963), The structure and formation of the myelin sheath, in “Mechanisms of Demyelination” (A. S. Rose and C. M. Pearson, eds.), McGraw-Hill, New York, pp. 1–43.
Swank, R. L. (1961), “A Biochemical Basis of Multiple Sclerosis,” Charles C. Thomas, Springfield, Ill.
Tasaki, I. (1968), “Nerve Excitation. A Macromolecular Approach,” Charles C. Thomas, Springfield, Ill.
Thompson, R. H. S. (1964), Lipolytic enzymes and demyelination, in “Metabolism and Physiological Significance of Lipids” (R. M. C. Dawson and E. N. Rhodes, eds.), Wiley & Sons, New York, pp. 541–551.
Tobias, J. M. (1955), J. Cell. Comp. Physiol., 46:183.
Tobias, J. M (1958), J. Cell. Comp. Physiol., 52:89.
Tobias, J. M. (1960), J. Gen. Physiol., 43:57.
Toman, J. E. P. (1949), Electroenceph. Clin. Neurophysiol, 1:33.
Vidal, J. C., B. N. Badano, A. O. M. Stoppani and A. Bovens (1966), Mem. Inst. Butantan Simp. Int., 33:913.
Vidal Breard, J. J. and V. E. Elias (1950), Arch. Farm. Bioquim. Tucman, 5:77.
Villegas, G. M. and R. Villegas (1960), J. Ulstrastruct. Res., 3:362.
Wallach, D. F. H. and P. H. Zahler (1966), Proc. Nat. Acad. Sci., 56:1552.
Walsh, R. R. and S. E. Deal (1959), Amer. J. Phvsiol., 197:547.
Walsh, R. R. and G. D. Webb (1963), Biochem. Pharmacol., 12:451.
Webb, G. D. and H. G. Mautner (1966), Biochem. Pharmacol., 15:2105.
Whittaker, V. P. (1961), Biochem. Pharmacol., 5:392.
Wilson, I. B. and S. Ginsburg (1955), Biochim. Biophys. Acta., 18:168.
Witter, R. F. and M. A. Cottone (1956), Biochim. Biophys. Acta, 22:364.
Witter, R. F., A. Morrison, and G. R. Shepardson (1957), Biochim. Biophys. Acta, 26:120.
Wooldridge, W. R. and C. Higginbottom (1938), Biochem. J., 32:1718.
Zeller, E. A. (1949), Helv. Chim. Acta, 32:94.
Zeller, E. A. (1951), Enzymes as essential components of bacterial and animal toxins, in “The Enzymes,” vol. 1, pt. 2 (J. B. Sumner and K. Myrback, eds.), Academic Press, New York, pp. 986–1013.
Zeller, E. A. (1966), Mem. Inst. Butantan Simp. Intern., 33:349.
Ziegler, F. D., L. Vázquez-Colón, W. B. Elliott, A. Taub, and C. Gans (1965), Biochemistry, 4:555.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Plenum Press, New York
About this chapter
Cite this chapter
Rosenberg, P. (1971). The Use of Snake Venoms as Pharmacological Tools in Studying Nerve Activity. In: Simpson, L.L. (eds) Neuropoisons. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2940-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2940-4_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2942-8
Online ISBN: 978-1-4684-2940-4
eBook Packages: Springer Book Archive